Trial Details
COMPLETEDBasic Information
| Clinical ID | c1058 |
|---|---|
| Identifier | NCT05807971 |
| Trial Title | Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Autoimmune Diseases |
| Interventions | DRUG: ATH-063|DRUG: Placebo |
Participant Information
| Sponsor | Athos Therapeutics Inc |
|---|---|
| City | Adelaide |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-04-06 |
|---|---|
| Primary Completion Date | 2024-02-08 |
| Completion Date | 2024-02-08 |